Effect of blood transfusion and cyclophosphamide on cardiac allograft survival in sensitized mice.
In the H-2-incompatible donor-recipient model in mice (BALB/c-->CBA/H), combination of donor-specific blood transfusion (DST) on the day -9 before transplantation with both pre- and posttransplant immunosuppression with cyclophosphamide (CY) interacted beneficially to produce significant donor-specific prolongation of cardiac graft survival. However, in recipients presensitized with donor-specific blood on the day -21, combination of DST with pre- and posttransplant CY immunosuppression did not act synergistically and graft survival in this group did not differ from that in presensitized mice treated with 2 doses of CY alone.